Fluorescent multiplex IHC (mIHC) for simultaneous staining CD4, CD8, PD1, TIM3 and cytokeratins were conducted in paired pre‐NAT and post‐NAT tumor samples. This evidence concerns the gene CD8A and neoplasm.